Use of anticonvulsants drugs for neuropathic painful conditions

Journal of the Pakistan Medical Association

Volumn 58, Issue 12, 2008, Pages 690-695

  Hussain, Aziza Mohammad ^a   Afshan, Gauhar ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; FLUPHENAZINE; GABAPENTIN; LAMOTRIGINE; MORPHINE; NORTRIPTYLINE; OPIATE; PHENYTOIN; PLACEBO; PREGABLIN; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ALLERGIC REACTION; ANALGESIC ACTIVITY; ANXIETY; ATAXIA; BLOOD DYSCRASIA; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL PRACTICE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COGNITION; CONSTIPATION; DIABETIC NEUROPATHY; DIARRHEA; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; EPIGASTRIC PAIN; EPILEPSY; ERYTHEMA; FATIGUE; GAIT DISTURBANCE; HUMAN; IRRITABILITY; LETHARGY; LIVER TOXICITY; LOW DRUG DOSE; MIGRAINE; NAUSEA; NAUSEA AND VOMITING; NEPHROLITHIASIS; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PERIPHERAL NERVOUS SYSTEM; POSTHERPETIC NEURALGIA; QUALITY CONTROL; RASH; REVIEW; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SOMNOLENCE; SYMPTOMATOLOGY; THIRST; THROMBOCYTE COUNT; TRANQUILIZING ACTIVITY; TREMOR; TRIGEMINUS NEURALGIA; UNSTEADINESS; WATER INTOXICATION; WEIGHT GAIN; XEROSTOMIA;

ALGORITHMS; ANTICONVULSANTS; DIABETIC NEUROPATHIES; HUMANS; NEURALGIA;

EID: 57449117529     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). Lancet 1962; 1: 839-40.
2. Benzon HT. The neuropathic pain scales. Reg Anesth Pain Med 2005; 30: 417-21.
3. Landmark CJ. Targets for antiepileptic drugs in the synapse. Med Sci Monit 2007; 13:1-7.
4. Johannessen Landmark C. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 2008; 22:27-47.
5. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118:289-305.
6. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1966; 29:265-7.
7. Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966; 15:129-36.
8. Dalessio DJ. Medical treatment of tic douloureux. J Chronic Dis 1966; 19:1043-8.
9. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol 1968; 19:129-36.
10. Nicol CF. A four year double-blind study of tegretol in facial pain. Headache 1969; 9:54-7.
11. Sturman RH, O'Brien FH. Non-surgical treatment of tic douloureux with carbamazepine (G32883). Headache 1969; 9:88-91.
12. Tayor JC, Brauer S, Espir. Long term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med j 1981; 57: 6-18.
13. Rull JA, Quibrera R, Gonzalez-Millan H, Lozano Castaneda O. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double blind crossover trial. Diabetologia. 1969; 5:215-8.
14. Wilton TD. Tegretol in the treatment of diabetic neuropathy. S Afr Med J. 1974; 48:869-72.
15. Gomez-Perez FJ, Choza R, Rios JM, Reza A, Huerta E, Aquilar CA et al. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res 1996; 27:525-9.
16. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977; 22: 196-9.
17. Chadda VS, Mathur MS. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978; 26:403-6.
18. Gidal BE. New and emerging treatment options for neuropathic pain. Am J Manag Care 2006; 12: S 269-78.
19. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280:1831-6.
20. Gorson KC, Schott C, Herman R, Ropper AH, Rand WM. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 1999; 66:251-2.
21. Kennedy ED, Maechler P, Wollheim CB. Efects of depletion of mitochordrial DNA in metabolism secretion coupling in INS-1 cells. Effects of gabapentin compared to amitriptyline on pain in diabetic neuropathy. Diabetes 1998; 47: 374-80.
22. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352:1324-34.
23. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia; a randomised controlled trial. JAMA 1998; 280:1837-42.
24. Rice AS, Maton S, Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia; a randomised, double-blind, placebo controlled study. Pain 2001; 94: 215-24.
25. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: result from a double-blind placebo controlled crossover trial. Pain 1997; 73: 223-30.
26. Lunardi G, Leandri M, Albano C, Caltrera S, Fracassi M, Rubino V, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997; 48:1714-7.
27. Eisenberg E, Alon N, Ishay A, Daoud D, Yarnitsky D. Lamotrigine in the